ID

25534

Description

Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00474838

Link

https://clinicaltrials.gov/show/NCT00474838

Keywords

  1. 9/5/17 9/5/17 -
Uploaded on

September 5, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 2 Diabetes Mellitus NCT00474838

Eligibility Type 2 Diabetes Mellitus NCT00474838

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed drug naïve type 2 diabetic patient with typical diabetic symptom (polydipsia, polyuria, unexplained weight loss) within recent 1 year
Description

Therapy naive Non-Insulin-Dependent Diabetes Mellitus | Symptoms Diabetic | Polydipsia | Polyuria | Unexplained weight loss

Data type

boolean

Alias
UMLS CUI [1,1]
C0919936
UMLS CUI [1,2]
C0011860
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C0241863
UMLS CUI [3]
C0085602
UMLS CUI [4]
C0032617
UMLS CUI [5]
C1828173
initial hba1c : 8.0 % ≤ hba1c < 12.0%
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known contraindication to insulin glargine, insulin glulisine, metformin, glimepiride
Description

Medical contraindication Insulin Glargine | Medical contraindication Insulin Glulisine | Medical contraindication Metformin | Medical contraindication glimepiride

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0907402
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C1313386
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0025598
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0061323
patients with proliferative diabetic retinopathy
Description

Proliferative diabetic retinopathy

Data type

boolean

Alias
UMLS CUI [1]
C0154830
severe liver disease or ast, alt ≥ 2.5 x uln
Description

Liver disease Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0151904
UMLS CUI [3]
C0151905
history of lactic acidosis
Description

Acidosis, Lactic

Data type

boolean

Alias
UMLS CUI [1]
C0001125
unstable or severe angina
Description

Angina, Unstable | Angina Pectoris Severe

Data type

boolean

Alias
UMLS CUI [1]
C0002965
UMLS CUI [2,1]
C0002962
UMLS CUI [2,2]
C0205082
congestive heart failure
Description

Congestive heart failure

Data type

boolean

Alias
UMLS CUI [1]
C0018802
chronic disease treated with continuous corticosteroid therapy
Description

Steroid therapy Chronic disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0008679
diagnosis of cancer
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
positive urine pregnancy test or plan to become pregnant during the clinical trial
Description

Urine pregnancy test positive | Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0430059
UMLS CUI [2]
C0032992

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00474838

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Therapy naive Non-Insulin-Dependent Diabetes Mellitus | Symptoms Diabetic | Polydipsia | Polyuria | Unexplained weight loss
Item
newly diagnosed drug naïve type 2 diabetic patient with typical diabetic symptom (polydipsia, polyuria, unexplained weight loss) within recent 1 year
boolean
C0919936 (UMLS CUI [1,1])
C0011860 (UMLS CUI [1,2])
C1457887 (UMLS CUI [2,1])
C0241863 (UMLS CUI [2,2])
C0085602 (UMLS CUI [3])
C0032617 (UMLS CUI [4])
C1828173 (UMLS CUI [5])
Glycosylated hemoglobin A
Item
initial hba1c : 8.0 % ≤ hba1c < 12.0%
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Insulin Glargine | Medical contraindication Insulin Glulisine | Medical contraindication Metformin | Medical contraindication glimepiride
Item
known contraindication to insulin glargine, insulin glulisine, metformin, glimepiride
boolean
C1301624 (UMLS CUI [1,1])
C0907402 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C1313386 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0025598 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0061323 (UMLS CUI [4,2])
Proliferative diabetic retinopathy
Item
patients with proliferative diabetic retinopathy
boolean
C0154830 (UMLS CUI [1])
Liver disease Severe | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
severe liver disease or ast, alt ≥ 2.5 x uln
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0151904 (UMLS CUI [2])
C0151905 (UMLS CUI [3])
Acidosis, Lactic
Item
history of lactic acidosis
boolean
C0001125 (UMLS CUI [1])
Angina, Unstable | Angina Pectoris Severe
Item
unstable or severe angina
boolean
C0002965 (UMLS CUI [1])
C0002962 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Steroid therapy Chronic disease
Item
chronic disease treated with continuous corticosteroid therapy
boolean
C0149783 (UMLS CUI [1,1])
C0008679 (UMLS CUI [1,2])
Malignant Neoplasms
Item
diagnosis of cancer
boolean
C0006826 (UMLS CUI [1])
Urine pregnancy test positive | Pregnancy, Planned
Item
positive urine pregnancy test or plan to become pregnant during the clinical trial
boolean
C0430059 (UMLS CUI [1])
C0032992 (UMLS CUI [2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial